Biostimulation

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.006906.06.15
Date of registration and renewal:05.06.2015
Dosage form: & nbspEffervescent tablets weighing 3.5 g.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAD-sources of multivitamins without mineral complexes
Composition: & nbspIngredients: vitamin premix "EM28304" (vitamins A (retinol), B1 (thiamine), B2 (riboflavin), B6 ​​(pyridoxine), B12 (cyanocobalamin), C (ascorbic acid), E (tocopherol), D3, K1, (Biotin), PP (nicotinamide), B5 (calcium pantothenate), Vs (folic acid), lewsea root extract dry, magnolia extract dry, glucose, sorbitol, citric acid, sodium carbonate, sweetener "Sladin 200K" (saccharinate sodium (E954) and cyclamate (E952), a flavor identical to the natural "Orange Juice 74016-71." The content of biologically active substances (mg / tab): vitamin A (retinol) 0.85, vitamin D3 0.0084, vitamin C (ascorbic acid) 101, vitamin PP (nicotinamide) 15.2, vitamin E (tocopherol) 11.8, calcium pantothenate 4.56 , vitamin B6 (pyridoxine) 1.85, vitamin B2 (riboflavin) 1.75, vitamin B1 (thiamine) 1.52, folic acid 0.59, vitamin K1 0.075, biotin 0.025, vitamin B12 cyanocobalamin) 0.0025, Schisandrine 0.1, ecdisten 0.2.
Scope: & nbspTo realize the population as a biologically active food additive - a source of schisandrine, an additional source of vitamins C, A, E, D3, PP, K1, B1, B2, B6, B12, pantothenic acid, folic acid, biotin containing ecdystene.
Suggested Usage: & nbspAdults take 1 tablet a day with meals, dissolving in 300 ml. water.
Contraindications:Violation of carbohydrate metabolism, individual intolerance of components, pregnancy and lactation, increased nervous excitability, insomnia, hypertension, severe atherosclerosis, impaired cardiac activity.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place, not accessible to children, at a temperature not exceeding 25 ° C.
Research protocols:Expert conclusion of FGUZ "Center for Hygiene and Epidemiology in Moscow" No. 04720 dated February 24, 2015.
Recipient:SANTEPHARM, LLCSANTEPHARM, LLC Russian Federation
Information update date: & nbsp02.04.2016
Instructions
Up